文献速递肿瘤 PET/CT

根治性前列腺切除术后生化失败患者的前瞻性18F-DCFPyL PSMA PET/CT评估

Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer.
PubMed 文献 · J Nucl Med · 2019-06-14

PSA<1.0 ng/mL者阳性率59.1%,PSA>1.0 ng/mL者阳性率88.9%。

要点

  • 18F-DCFPyL PET/CT在术后生化失败患者中总阳性率为67.7%。
  • PSA<1.0 ng/mL时阳性率仍达59.1%,提示低PSA水平也可检出病灶。
  • 所有病灶中位SUVmax为11.6(范围1.5-57.6)。

核心结论

  • 根治性前列腺切除术后生化失败患者中,多数经18F-DCFPyL PET/CT检出提示前列腺癌的摄取灶,即使血清PSA水平较低。

主要发现

  • PSA<1.0 ng/mL患者中影像阳性率为59.1%,PSA>1.0 ng/mL患者中为88.9%。
  • 所有病灶中位SUVmax为11.6(范围1.5-57.6)。

临床怎么用

  • 对根治性前列腺切除术后生化失败且常规影像阴性的患者,可考虑行18F-DCFPyL PSMA PET/CT定位病灶。
  • 低PSA水平(<1.0 ng/mL)患者仍有较高比例可检出提示性摄取灶,解读时不应仅因PSA低而排除检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our purpose is to provide the results of a prospective study evaluating prostate-specific membrane antigen-targeted 18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid) PET/CT in patients with biochemical failure after radical prostatectomy for prostate cancer (PCa). Methods: Thirty-one patients with postprostatectomy serum prostate-specific antigen (PSA) levels of at least 0.2 ng/mL and negative conventional imaging results were enrolled in this study and imaged with 18F-DCFPyL PET/CT. A consensus central review identified foci of radiotracer uptake consistent with sites of PCa. Descriptive statistics were used. Results: Twenty-one patients (67.7%) had at least 1 finding on 18F-DCFPyL PET/CT consistent with a site of PCa. Imaging was positive in 59.1% of patients with a PSA level of less than 1.0 ng/mL and in 88.9% of patients with a PSA level of more than 1.0 ng/mL. The median SUVmax across all lesions was 11.6 (range, 1.5-57.6). Conclusion: In this prospective study using the prostate-specific membrane antigen-targeted PET agent 18F-DCFPyL, most patients with biochemical failure after radical prostatectomy had foci of suggestive uptake, even at low serum PSA levels.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rowe SP, Campbell SP, Mana-Ay M, et al. Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer. J Nucl Med. 2019. PMID: 31201249. doi:10.2967/jnumed.119.226514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。